CD4 and systemic lupus erythematosus: Stable expression of CD40 protein on cytomembrane vesicles can target CD4+ T cells and inhibit B cell proliferation to treat systemic lupus erythematosus (SLE) through CD40/CD40L interaction blockade [133].